BIOSTAR PHARM-B (02563) Sets 25 Mar 2026 Board Meeting to Review FY 2025 Results and Dividend Proposal

Bulletin Express03-11 18:02

Beijing Biostar Pharmaceuticals Co., Ltd. (BIOSTAR PHARM-B, 02563) will convene a board meeting on 25 March 2026 in Beijing to address three core agenda items:

1. Approval and publication of the consolidated annual results for the financial year ended 31 December 2025. 2. Consideration of a final dividend recommendation for shareholders. 3. Handling of other routine corporate matters.

The meeting will be chaired by Dr. Tang Li, who serves as Chairman and Executive Director. The current Board comprises nine members, including four executive directors, two non-executive directors and three independent non-executive directors.

The company released the meeting schedule through an official announcement dated 11 March 2026, in accordance with Hong Kong listing requirements.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1111882992?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-11 18:02","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1111882992","market":"hk","top_or_hot":-1,"title":"BIOSTAR PHARM-B (02563) Sets 25 Mar 2026 Board Meeting to Review FY 2025 Results and Dividend Proposal","media":"Bulletin Express","content":"<p>Beijing Biostar Pharmaceuticals Co., Ltd. (BIOSTAR PHARM-B, 02563) will convene a board meeting on 25 March 2026 in Beijing to address three core agenda items:</p>\n<p>1. Approval and publication of the consolidated annual results for the financial year ended 31 December 2025.  \n2. Consideration of a final dividend recommendation for shareholders.  \n3. Handling of other routine corporate matters.</p>\n<p>The meeting will be chaired by Dr. Tang Li, who serves as Chairman and Executive Director. The current Board comprises nine members, including four executive directors, two non-executive directors and three independent non-executive directors.</p>\n<p>The company released the meeting schedule through an official announcement dated 11 March 2026, in accordance with Hong Kong listing requirements.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BIOSTAR PHARM-B (02563) Sets 25 Mar 2026 Board Meeting to Review FY 2025 Results and Dividend Proposal</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBIOSTAR PHARM-B (02563) Sets 25 Mar 2026 Board Meeting to Review FY 2025 Results and Dividend Proposal\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-03-11 18:02</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Beijing Biostar Pharmaceuticals Co., Ltd. (BIOSTAR PHARM-B, 02563) will convene a board meeting on 25 March 2026 in Beijing to address three core agenda items:</p>\n<p>1. Approval and publication of the consolidated annual results for the financial year ended 31 December 2025.  \n2. Consideration of a final dividend recommendation for shareholders.  \n3. Handling of other routine corporate matters.</p>\n<p>The meeting will be chaired by Dr. Tang Li, who serves as Chairman and Executive Director. The current Board comprises nine members, including four executive directors, two non-executive directors and three independent non-executive directors.</p>\n<p>The company released the meeting schedule through an official announcement dated 11 March 2026, in accordance with Hong Kong listing requirements.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02563","symbol_name":"华昊中天医药-B","start_time":0,"source_url":"","article_id":"1111882992","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1111882992","pubTimestamp":1773223360,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Beijing Biostar Pharmaceuticals Co., Ltd. (BIOSTAR PHARM-B, 02563) will convene a board meeting on 25 March 2026 in Beijing to address three core agenda items: 1. Approval and publication of the...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02563":"华昊中天医药-B"},"translate_title":"BIOSTAR PHARM-B(02563)定于2026年3月25日召开董事会会议，审查2025财年业绩和股息提案","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02563":1},"content_text":"Beijing Biostar Pharmaceuticals Co., Ltd. (BIOSTAR PHARM-B, 02563) will convene a board meeting on 25 March 2026 in Beijing to address three core agenda items:\n1. Approval and publication of the consolidated annual results for the financial year ended 31 December 2025.  \n2. Consideration of a final dividend recommendation for shareholders.  \n3. Handling of other routine corporate matters.\nThe meeting will be chaired by Dr. Tang Li, who serves as Chairman and Executive Director. The current Board comprises nine members, including four executive directors, two non-executive directors and three independent non-executive directors.\nThe company released the meeting schedule through an official announcement dated 11 March 2026, in accordance with Hong Kong listing requirements.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"dataReport,SGX","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1111882992","isCrawlerRequest":true}